2LKK
Human L-FABP in complex with oleate
SOLUTION NMR
NMR Experiment | ||||||||
---|---|---|---|---|---|---|---|---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
1 | 2D 1H-15N HSQC | 20 mM potassium phosphate, 150 mM sodium chloride, 0.05 % sodium azide, 2 mM [U-15N] human liver fatty acid binding protein, 10 mM potassium oleate, 95 % H2O, 5 % D2O | 95% H2O/5% D2O | 150 | 6.0 | ambient | 298 | |
2 | 2D 1H-1H TOCSY | 20 mM potassium phosphate, 150 mM sodium chloride, 0.05 % sodium azide, 3 mM human liver fatty acid binding protein, 15 mM [U-13C] potassium oleate, 95 % H2O, 5 % D2O | 95% H2O/5% D2O | 150 | 6.0 | ambient | 298 | |
3 | 2D 1H-1H NOESY | 20 mM potassium phosphate, 150 mM sodium chloride, 0.05 % sodium azide, 3 mM human liver fatty acid binding protein, 15 mM [U-13C] potassium oleate, 95 % H2O, 5 % D2O | 95% H2O/5% D2O | 150 | 6.0 | ambient | 298 | |
4 | 3D 1H-15N NOESY | 20 mM potassium phosphate, 150 mM sodium chloride, 0.05 % sodium azide, 2 mM [U-15N] human liver fatty acid binding protein, 10 mM potassium oleate, 95 % H2O, 5 % D2O | 95% H2O/5% D2O | 150 | 6.0 | ambient | 298 | |
5 | 3D 1H-15N TOCSY | 20 mM potassium phosphate, 150 mM sodium chloride, 0.05 % sodium azide, 2 mM [U-15N] human liver fatty acid binding protein, 10 mM potassium oleate, 95 % H2O, 5 % D2O | 95% H2O/5% D2O | 150 | 6.0 | ambient | 298 | |
6 | 2D 1H-13C HSQC | 20 mM potassium phosphate, 150 mM sodium chloride, 0.05 % sodium azide, 3 mM human liver fatty acid binding protein, 15 mM [U-13C] potassium oleate, 95 % H2O, 5 % D2O | 95% H2O/5% D2O | 150 | 6.0 | ambient | 283 | |
7 | 3D 1H-13C NOESY aliphatic | 20 mM potassium phosphate, 150 mM sodium chloride, 0.05 % sodium azide, 3 mM human liver fatty acid binding protein, 15 mM [U-13C] potassium oleate, 95 % H2O, 5 % D2O | 95% H2O/5% D2O | 150 | 6.0 | ambient | 283 |
NMR Spectrometer Information | |||
---|---|---|---|
Spectrometer | Manufacturer | Model | Field Strength |
1 | Bruker | DMX | 500 |
2 | Bruker | AVANCE | 800 |
NMR Refinement | ||
---|---|---|
Method | Details | Software |
molecular dynamics | CYANA |
NMR Ensemble Information | |
---|---|
Conformer Selection Criteria | final MD steps |
Conformers Calculated Total Number | 26 |
Conformers Submitted Total Number | 10 |
Representative Model | 1 (last md step) |
Computation: NMR Software | ||||
---|---|---|---|---|
# | Classification | Version | Software Name | Author |
1 | structure solution | CYANA | 2.1 | Guntert, Mumenthaler and Wuthrich |
2 | refinement | Discover | 2000 | Accelrys Software Inc. |
3 | structure solution | Discover | 2000 | Accelrys Software Inc. |
4 | data analysis | NMRView | 8.0 | Johnson, One Moon Scientific |
5 | peak picking | NMRView | 8.0 | Johnson, One Moon Scientific |
6 | collection | XwinNMR | 3.5 | Bruker Biospin |
7 | processing | XwinNMR | 3.5 | Bruker Biospin |
8 | collection | TopSpin | 1.3 | Bruker Biospin |
9 | processing | TopSpin | 1.3 | Bruker Biospin |